
HS Sprint project: ‘From coffee bean to improved preterm breath’
Africa
Summary
Neonatal mortality in Sub-Saharan Africa is the highest worldwide, with prematurity and its complications, including apnea of prematurity (AOP) and hypoxia, being major contributors. Caffeine is the key pharmacological treatment for AOP, but remains largely inaccessible in Sub-Saharan Africa. This project unites local stakeholders—including healthcare providers, pharmacists, and policymakers—in Malawi to collaboratively address barriers to caffeine availability and co-create implementation strategies. We aim to improve access to this essential medication, advancing neonatal healthcare in this region.
More information about this project
Do you have questions about this project or do you want to receive more information? Please contact the main applicant of this project: Kelly Storm